Author(s) :

Aqsa shahid.

Volume/Issue :

Abstract :

Myocardial infarction (MI) is a major cause of mortality to human beings all over the world with an estimated 19.91 million deaths in 2024 and 32 percent of global mortality. Coronary artery occlusion and myocardial ischemia are caused by MI, mostly through the rupture or erosion of atherosclerotic plaque. MI is very prevalent in low- and middle-income countries due to the lack of access to healthcare facilities and exposure to risk factors such as smoking, diabetes, and other hypertension. The prognosis of the patients has also been improved by improvement in treatment and diagnostic modalities. Older therapies such as PCI and thrombolysis continue to be very important in acute treatment, drug-eluting stents and CABG and newer therapies like stem cell and gene therapies all have potential roles in the long-term repair of the heart. The additional focus on personal approach, along with the advancement of diagnostics and imaging, is expected to contribute to the reduction of morbidity and mortality caused by MI and deliver improved prognoses to patients.

No. of Downloads :

0